Quibim

Quibim plans to become the global leader in virtual biopsies, using quantitative imaging biomarkers to unlock complex diseases signals in medical images.Clinicians, researchers and pharmaceutical companies use Quibim Precision®, an ecosystem of radiological medical image analysis applications, to assess every part of the body and in different clinical scenarios, from disease detection to monitoring the efficacy of new treatments.

68.7logo
logo
logo
logo
logo
logo
68.7
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logo
logologologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 8.57 M
$ 42.92 M
Funding
$ 8.57 M
$ 42.92 M
Statistics
logo
NA
Action

Quibim plans to become the global leader in virtual biopsies, using quantitative imaging biomarkers to unlock complex diseases signals in medical images.Clinicians, researchers and pharmaceutical companies use Quibim Precision®, an ecosystem of radiological medical image analysis applications, to assess every part of the body and in different clinical scenarios, from disease detection to monitoring the efficacy of new treatments.

Overview
Last verified: 10/15/2022
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
logologologo
0and0